FHA PCOM (n = 104) | FHA (n = 85) | p | |
---|---|---|---|
Ovulatory cycle rate | 80.8 % (n = 84) | 77.7 % (n = 66) | NS |
Cancelled cycles rate | 19.2 % (n = 20) | 22.4 % (n = 19) | NS |
- for excessive response | 12.5 % (n = 13) | 10.6 % (n = 9) | NS |
- for poor response | 1.9 % (n = 2) | 0 % (n = 0) | NS |
- for ovarian cyst | 0 % (n = 0) | 5.9 % (n = 5) | NA |
- other | 4.8 % (n = 5) | 5.9 % (n = 5) | NS |
Positive pregnancy test rate | 32.7 % (n = 34) | 24.7 % (n = 21) | NS |
Clinical pregnancy rate | 28.8 % (n = 31) | 23.5 % (n = 20) | NS |
Clinical ongoing pregnancy rate | 26.9 % (n = 28) | 20.0 % (n = 17) | NS |
Miscarriage rate | 2.9 % (n = 3) | 3.5 % (n = 3) | NS |
Multiple pregnancy rate | 1.0 % (n = 1) | 2.4 % (n = 2) | NS |
Biochemical pregnancy rate | 2.9 % (n = 3) | 1.2 % (n = 1) | NS |
Mean (+/− S.D) starting doses of GnRH chosen for the first cycle (μg): | |||
- intravenous | 4.9 (+/− 0.3) | 5.3 (+/− 1.3) | NS |
- subcutaneous | 12.0 (+/− 4.6) | 15.0 (+/− 4.5) | NS |
Mean (+/− S.D) starting doses of GnRH (all cycles) (μg): | |||
- intravenous | 5.7 (+/− 2.1) | 5.5 (+/− 2.1) | NS |
- subcutaneous | 11.8 (+/− 4.9) | 13.1 (+/− 6.3) | NS |